Genmab
GMAB
$28.44
Share price
2.04%
Change (1 day)
-27.12%
Change (1 year)
Categories
Market capitalization of Genmab (GMAB)
Market cap: C$17.79 Billion
As of April 2025 Genmab has a market cap of C$17.79 Billion. This makes Genmab the world's 1370th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Genmab from 2010 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$17.79 B | -7.63% |
| 2024 | C$19.26 B | -30.17% |
| 2023 | C$27.58 B | -27.28% |
| 2022 | C$37.93 B | 13.66% |
| 2021 | C$33.37 B | -1.91% |
| 2020 | C$34.02 B | 80.69% |
| 2019 | C$18.82 B | 37.85% |
| 2018 | C$13.65 B | 7.78% |
| 2017 | C$12.67 B | -6.01% |
| 2016 | C$13.48 B | 21.49% |
| 2015 | C$11.09 B | 185.39% |
| 2014 | C$3.88 B | 79.89% |
| 2013 | C$2.16 B | 213.39% |
| 2012 | C$0.68 B | 130.91% |
| 2011 | C$0.29 B | -50.7% |
| 2010 | C$0.60 B |
End of Day market cap according to different sources
On Apr 24th, 2025 the market cap of Genmab was reported to be:
